Title: Assessing CPP requirements for drug registration processes in the Region of the Americas towards more timely access to medicines and more convergent regulatory approaches.
Cross-cutting areas: Authorization, Registration and Licensing of products and facilities and Good Regulatory Practices and Regulatory Sciences
Initiator: Latin America Federation of the Pharmaceutical Industry - FIFARMA
|